Project CBD

FEBRUARY 28, 2023

1 SPINS’ CBD category typically includes sales of products that contain hemp-based CBD extracts, including CBD oils, gummies, and capsules. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022. Accessed October 17, 2022. Accessed October 17, 2022. Accessed October 17, 2022. 2021;56:530-543.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. 30 May 2019.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Cannabis Law Report

DECEMBER 15, 2021

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.

Pharmaceutical 52

Pharmaceutical Cannabinoids Business Extraction 52

Cannabis Law Report

OCTOBER 26, 2019

The US subsidiary of GW Pharmaceuticals, behind the only FDA-approved cannabis extract-based medicine, is lobbying in all 50 states. GW is the world’s oldest and largest pharmaceutical company solely focused on producing medicines derived from cannabis plants, which it grows in Britain. By Nikitha Sattiraju.

Pharmaceutical 45

Pharmaceutical Research and Development Banking Therapy 45

Cannabis Law Report

SEPTEMBER 8, 2021

Flora will now have the ability to quickly and efficiently reference and manage information at its cultivation and extraction facility, collect and analyze data, derive insights to find cost efficiencies, and ensure accuracy. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp.

Supply Chain 73

Supply Chain Pharmaceutical Seed-To-Sale Events 73

Cannabis Law Report

AUGUST 9, 2021

The company’s innovative technology enables the provision of an exact amount of active ingredients through oral ingestion, using a high concentration of cannabinoids or medical cannabis extract in a homogeneous, uniform and stable formulation which can be administered in the form of oral capsules, syrups or buccal sprays. Of Cannassure.

Cannabinoids 98

Cannabinoids Pharmaceutical Treatment Patients 98

Cannabis Law Report

NOVEMBER 3, 2021

This is a strategic opportunity for us to reach the widest audience of customers possible while being the first and, at the moment, the only company with a permit to market cannabis extracts for inhalation in Germany specifically and in Europe in general.

Extraction 52

Extraction Pharmaceutical Patients Treatment 52

MJ Business Attorneys

JUNE 29, 2018

So for now, we wait in anticipation for the DEA to commence proceedings to determine how to amend the scheduling of CBD under the CSA in a way that will allow for Epidiolex to be prescribed by health care providers and dispensed by pharmaceutical companies appropriately and legally.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

Cannabis Law Report

JUNE 21, 2021

Dr. Dadi Segal , Founder and CEO of Panaxia Israel : “We are excited to be the first and exclusive company in Europe to receive a marketing permit for inhaled medical cannabis extracts. It is a global pharma company, that develops, manufactures and markets advanced medical cannabis products of pharmaceutical high quality.

Extraction 45

Extraction Pharmaceutical Research and Development Patients 45

Cannabis Law Report

JUNE 1, 2022

This acquisition will accelerate Khiron’s growth in Europe by controlling the complete value chain for its products and gaining direct access to German pharmacies. Pharmadrug GmbH has been active worldwide for almost 40 years as a manufacturer and wholesaler of medicinal products and active pharmaceutical ingredients.

Pharmaceutical 52

Pharmaceutical Medicine Extraction Cannabinoids 52

The Cannigma

FEBRUARY 1, 2023

Advocate for the rescheduling of cannabis to improve access to cannabis for research purposes, and scientific funding for novel cannabinoid-based cancer therapies. His team is using novel techniques aimed at untangling the complex interactions between specific plant extracts with cancer cancer cells. Use harm reduction techniques (i.e.

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

Cannabis Law Report

JANUARY 19, 2022

(ASX: LGP) (“LGP”), a vertically integrated cannabis manufacturer, that AMP has been appointed as marketer and distributor of LGP medical cannabis extracts to pharmacies and clinics in Germany , including exclusive distributor of LGP’s 20:5 LGP Classic and 10:10 LGP Classic extract oils. ” Ms.

Extraction 52

Extraction Oil Research and Development Medicine 52

Canna Law Blog

MARCH 2, 2019

.” Gottleib qualified this by saying that CBD access is not a straightforward issue because CBD has already been investigated and approved as a drug, Epiodiolex , which generally means CBD cannot be added to food. This is where things get interesting.

Hemp 107

Hemp CBD Programs Food 107

Veriheal

AUGUST 9, 2023

This new research has increased our hopes for an alternate CBD source, which may increase the availability of CBD-based products, reduce purchase costs, and guarantee THC-free extracts. Even more, CBD is the first FDA-approved pharmaceutical drug for two rare forms of epileptic seizures in kids.

CBD 96

CBD Cannabinoids THC Extraction 96

Cannabis Law Report

AUGUST 19, 2021

Mydecine has exclusive access to a full cGMP certified pharmaceutical manufacturing facility with the ability to import/export, cultivate, extract/isolate, and analyze active mushroom compounds with full government approval through Health Canada.

Medicine 98

Medicine Research and Development Therapy Pharmaceutical 98

Cannabis Law Report

JUNE 28, 2021

As such, the company is creating a new standard in the industry by providing better and safer access to such cannabis medications. It develops high-quality medical cannabis extract formulas, medical device vaporisers, and other innovative delivery methods. Kanabo is an established leader in medical cannabis research and innovation.

Research and Development 105

Research and Development Chronic Pain Medicine Policy 105

Cannabis Law Report

JULY 24, 2021

With full government approval through Health Canada for exclusive access to a full cGMP-certified pharmaceutical manufacturing facility, Mydecine continues to advance the clinical progress in its 4 leading novel compounds, MYCO-001 through 004 with the ability to import or export, cultivate, extract or isolate, and analyze active mushroom compounds.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Cannabis Law Report

SEPTEMBER 14, 2021

By uniting the strength of Open Book Extract’s quality innovation and custom product development with Radicle Science’s unbiased scientific rigor in natural products research, we can impact every stage of the product life cycle from ideation to validation. About Open Book Extracts. About Radicle Science. Headquartered in Roxboro, N.C.,

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Miss Marijuana

NOVEMBER 4, 2020

The brand’s growers are pharmaceutical experts who think of the user’s best needs every step of the way. The company has a wide range of products including strain-specific extracted oil, activated THC distillate, and specially-formulated cannabinoid medicine. MPX – Melting Point Extracts. Abx – AbsoluteXrracts.

Strains 98

Strains Concentrates Extraction Pharmaceutical 98

Veriheal

MARCH 7, 2023

Beis expressed his excitement about the factory being the largest pharmaceutical facility in Europe, where a medical cannabis industry is sprouting across Luxembourg, Germany, and Malta. “A M edicinal-grade cannabis will be cultivated inside a 25,000-square-foot extraction and processing facility as part of the Greek Kaya Project.

Marijuana 98

Marijuana Pharmaceutical Medicine Cultivation 98

Cannabis Law Report

SEPTEMBER 7, 2022

The acquisition by Ramm provides access to HemPoland’s distribution network, recognized premium brands, hemp oil extraction technologies, and an additional synergistic foothold into the European market following the acquisition of Sicily-based Canapar Corp. (CSE: TGOD) for cash consideration of C$1.2 HemPoland S.p.a.

Hemp 59

Hemp Pharmaceutical Extraction Cannabinoids 59

Canna Care Docs

SEPTEMBER 18, 2020

Yes, you will be able to upload your records directly to your patient portal which you will receive access to. These oils are extracted by the licensed Pharmaceutical Processors that have been selected to grow, process, and dispense medical cannabis in Virginia. Do I Need to Present my Medical Records to Canna Care Docs?

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

Cannabis Law Report

JULY 6, 2021

This, in turn, would allow the local pharmaceutical industry to provide cheap cannabis-based medicine for Brazilian patients, an argument defended by Jandira Feghali (Communist Party) during the voting session of Bill 399/2015. Catarina is one of them, and she cultivates for her own use.

Therapy 105

Therapy Oil Cultivation Research and Development 105

Veriheal

SEPTEMBER 20, 2021

Now, the latest trend among folks living in states without access to legal cannabis is THC-O. Legalization has helped mitigate some of these issues by increasing access to lab-tested cannabis, which identifies levels of cannabinoids and terpenes as well as dangerous/banned substances. At one time, it was all about THC. Then came CBD.

THC 98

THC Cannabinoids Vaping Hemp 98

The Cannigma

JUNE 15, 2021

For now, if you have access to quality CBD products, there’s no reason to prioritize CBG products. Easy access. Another factor that increased CBD’s popularity was the FDA approval of an antiepileptic cannabis-based drug named Epidiolex — a highly concentrated CBD extraction mixed with sesame oil and some flavoring.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

AUGUST 12, 2021

Since 2013, medicinal cannabis has been legalized in the Czech Republic due to the amendment to the Act on pharmaceuticals, otherwise known as Act No. With medical research indicating that using the plant provides significant medical benefits, the Czech Chamber of Deputies suggested a revision to the government’s Act on pharmaceuticals.

Legalization 59

Legalization Pharmaceutical Safety Extraction 59

Cannabis Law Report

OCTOBER 26, 2021

Following this selection, Tilray will supply a variety of its pharmaceutical-grade medical cannabis products, including extracts and dried flower with different degrees of THC and CBD for patients with varying medical conditions.

Pharmaceutical 52

Pharmaceutical Research and Development Patients Access 52

Cannabis Law Report

JUNE 24, 2021

and RAD – are well recognized across the country and through GWNG we will benefit from speed-to-market in Quebec and consumers will have access to our high quality, fairly priced products.”. “Products across all of our brands – Pura Vida, Purefarma, Premium 5, feelgood., Follow Heritage’s Purefarma, Pura Vida, Premium 5, and feelgood.

Extraction 73

Extraction Recreational Pharmaceutical Packaging 73

Canna Care Docs

DECEMBER 11, 2018

Ultimately, beyond increased access, a big reason that seniors are turning to cannabis is that it helps with a range of health issues. Another important aspect for seniors is that medicinal cannabis users tend to take less pharmaceutical drugs. Accessed December 5 2018. Accessed December 5 2018. Let’s take a closer look.

Chronic Pain 76

Chronic Pain Sleep Clinical Trials Medicine 76

Cannabis Law Report

JANUARY 14, 2022

Is it a natural response to the fact that recreational is supposedly on the way or a the report suggests it’s hard as a patient to access so therefore people are just giving up. The current lack of market growth reflects an unfortunate reality in Germany that patient access to medical cannabis is still quite low.

Pharmaceutical 52

Pharmaceutical Extraction Oil Patients 52

Cannabis Law Report

DECEMBER 14, 2019

Clinical stage CBD company Botanix Pharmaceuticals (ASX: BDA ) works on using cannabidiol (CBD) in its treatment of skin conditions including acne, psoriasis, dermatitis and rosacea. Investing in cannabis stocks on the ASX: Investing in ASX cannabis stocks. Keep up with major deals and investment opportunities in marijuana.

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

Project CBD

MAY 3, 2023

Remember, the pharmaceutical model is “this medicine addresses this specific target.” There are pharmaceuticals for ADHD or behavioral issues, for example, which target this receptor. How easy is it to access CBG products? People often ask: How is it possible that these compounds can do so many things?

Cannabinoids 213

Cannabinoids Sleep Clinical Trials CBD 213

Cannabis Law Report

APRIL 29, 2022

The Berlin-based company has a Fast Track Access platform that enables producers worldwide to become part of the German market and focuses on long-term collaborations and carries products such as dried flowers, extracts, Dronabinol and pharmaceutical-grade CBD. Miracle Valley’s operations are based in Mission, B.C.

Pharmaceutical 59

Pharmaceutical Cultivation Extraction Patients 59

Project CBD

AUGUST 23, 2023

Earlier this year, the Food & Drug Administration disclosed that it would not regulate non-pharmaceutical CBD products, thereby putting the onus on Congress to devise an appropriate regulatory framework for cannabidiol and other hemp-derived cannabinoids. Caffeine can also be found in pharmaceutical 33 and non-pharmaceutical products.)

Cannabinoids 142

Cannabinoids Hemp THC Safety 142

CannaTech

FEBRUARY 25, 2019

Kanabo’s proprietary medical cannabis extracts focus on sleep disorders and post-traumatic stress disorder, and are specially formulated for vaporization with the medically certified VapePod vaporizer platform. Accessible on any mobile device, the system’s dashboard provides full control over any grow operation from anywhere in the world.

Research and Development 85

Research and Development Hybrid Treatment Strains 85

Cannabis Law Report

MARCH 25, 2020

Panaxia Israel has just imported from the US hemp extracts from which it will manufacture CBD-rich cannabis products. Essence extraction was conducted in a facility jointly operated by Panaxia and Ultra Health located in New Mexico , US. About Panaxia Israel. and constitutes the Group’s cannabis division.

Oil 45

Oil Pharmaceutical Epilepsy Extraction 45

Cannabis Law Report

JULY 11, 2019

We believe that Farmalabor’s extensive experience of the Italian pharmaceutical industry makes it the ideal partner to unlock the full potential of this local market.”. EMMAC is the European medical cannabis company, working to join together the latest science and research with cutting-edge cultivation, extraction and production.

Access 40

Access Supply Chain Research and Development Pharmaceutical 40